Company
CanadaPublic company, NYSE: BHCBausch Health Companies Inc. (NYSE: BHC), Steinbach, Canada – FDA Inspections
Inspection records and compliance data for Bausch Health Companies Inc. in Steinbach. 6 FDA inspections on record, last inspected May 19, 2023. Publicly traded as NYSE: BHC.
Company Profile
This profile covers Bausch Health Companies Inc. based in Steinbach, Canada.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 0
- NAI
- 6
- Form 483s
- 0
- Warning letters
- 0
First inspected August 7, 2009. Last inspected May 19, 2023.
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 19, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1207309 |
| May 18, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1057827 |
| September 9, 2016 | NAI | Human Drugs · Drug Quality Assurance | 991127 |
| May 30, 2014 | NAI | Human Drugs · Drug Quality Assurance | 886644 |
| March 1, 2012 | NAI | Human Drugs · Drug Quality Assurance | 770131 |
| August 7, 2009 | NAI | Human Drugs · Drug Quality Assurance | 605456 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 9 inspections · last October 6, 2025
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bausch Health Companies Inc.
Stock ticker
BHC
Exchange
NYSE
Share price
$7.99
Market cap
$3.0B
Price as of
November 6, 2026
FEI Number
3002806613
Canada Business Number
138454145
Address
100 Life Sciences Pky, Box 21390, Steinbach, Canada
Country
Canada
ID: 3190f4ed-695e-491f-a57e-1ef128f7e2af